Evaxion A/S (NASDAQ: EVAX), a clinical-stage TechBio company, will provide a business update and report its third quarter 2025 financial results on November 6, 2025.
The company's Executive Management will host a conference call and webcast on the same day at 14:30 CET/08:30 EST to present the update and results and take questions.
To join the conference call, listen to the presentation and ask verbal questions, please register in advance.
Author's summary: Evaxion announces business update and Q3 2025 results.